Up to 15 medical devices will be enrolled next year in a new FDA pilot program that aims to boost agency engagement with manufacturers early on in a product’s development, the agency said Tuesday.
The Food and Drug Administration outlined its plans for the first phase of its Total Product Life Cycle Advisory Program, also known as the TAP Pilot program, in a Federal Register notice slated to officially publish Wednesday. The program is one of the commitments the FDA made in its user fee agreement with the medical device industry. Industry user fees, which were reauthorized for the next ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.
